Clearday, Inc. (CLRD)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -7.53 Million USD | 30.48% |
| 2021 | -18.08 Million USD | -19.45% |
| 2020 | -12.51 Million USD | -33.37% |
| 2019 | -8.36 Million USD | 99.9% |
| 2018 | -7.07 Million USD | 14.9% |
| 2017 | -7.6 Million USD | -85846.81% |
| 2016 | -8.97 Million USD | 11.63% |
| 2015 | -6.14 Million USD | 99.9% |
| 2014 | -6.91 Million USD | -17.41% |
| 2013 | -10.89 Million USD | 4.93% |
| 2012 | -10.61 Million USD | -80611.51% |
| 2011 | -13.66 Million USD | -5.47% |
| 2010 | -12.11 Million USD | 56.78% |
| 2009 | -12.16 Million USD | 99.77% |
| 2008 | -10.93 Million USD | -40.14% |
| 2007 | -6.75 Million USD | 69.16% |
| 2006 | -26.97 Million USD | -107.56% |
| 2005 | -10.87 Million USD | 52.03% |
| 2004 | -25.45 Million USD | -173.16% |
| 2003 | -11.01 Billion USD | 43.75% |
| 2002 | -19.58 Billion USD | -8.18% |
| 2001 | -18.1 Billion USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -978.42 Thousand USD | 42.45% |
| 2023 Q1 | -1.7 Million USD | 51.85% |
| 2023 Q3 | -646.34 Thousand USD | 33.94% |
| 2022 Q4 | -3.53 Million USD | -218.38% |
| 2022 FY | - USD | 30.48% |
| 2022 Q3 | -1.1 Million USD | 28.67% |
| 2022 Q1 | -2.21 Million USD | -371.2% |
| 2022 Q2 | -1.55 Million USD | 29.76% |
| 2021 Q4 | -469.77 Thousand USD | 91.64% |
| 2021 FY | - USD | -19.45% |
| 2021 Q1 | -3.64 Million USD | -99.44% |
| 2021 Q2 | -3.55 Million USD | 2.64% |
| 2021 Q3 | -5.61 Million USD | -58.06% |
| 2020 Q2 | -745 Million USD | 31.02% |
| 2020 Q1 | -1.08 Billion USD | 44.16% |
| 2020 Q4 | -1.83 Million USD | 43.45% |
| 2020 Q3 | -3.23 Million USD | 99.57% |
| 2020 FY | - USD | -33.37% |
| 2019 Q2 | -2.6 Billion USD | -10.41% |
| 2019 Q4 | -1.93 Billion USD | 18.88% |
| 2019 FY | - USD | 99.9% |
| 2019 Q1 | -2.36 Billion USD | 38.51% |
| 2019 Q3 | -2.38 Billion USD | 8.59% |
| 2018 Q3 | -2.18 Billion USD | -594665.22% |
| 2018 Q1 | -2.19 Billion USD | 69.62% |
| 2018 Q4 | -3.84 Billion USD | -75.57% |
| 2018 Q2 | 368 Thousand USD | 100.02% |
| 2018 FY | - USD | 14.9% |
| 2017 FY | - USD | -85846.81% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q1 | 568 Million USD | -89.11% |
| 2017 Q4 | -7.22 Billion USD | 0.0% |
| 2016 FY | - USD | 11.63% |
| 2016 Q3 | -2.84 Billion USD | 7.59% |
| 2016 Q4 | 5.21 Billion USD | 283.14% |
| 2016 Q2 | -3.08 Billion USD | -523.8% |
| 2016 Q1 | 727 Million USD | -92.36% |
| 2015 Q1 | -3.68 Billion USD | -13.95% |
| 2015 Q3 | -2.88 Billion USD | 2.27% |
| 2015 FY | - USD | 99.9% |
| 2015 Q4 | 9.51 Billion USD | 429.57% |
| 2015 Q2 | -2.95 Billion USD | 19.86% |
| 2014 Q4 | -3.23 Billion USD | -3.79% |
| 2014 Q2 | -3.15 Billion USD | -12.83% |
| 2014 Q1 | -2.79 Billion USD | 55.91% |
| 2014 FY | - USD | -17.41% |
| 2014 Q3 | -3.11 Billion USD | 1.33% |
| 2013 Q3 | -3.37 Billion USD | -41.6% |
| 2013 Q4 | -6.34 Billion USD | -88.4% |
| 2013 FY | - USD | 4.93% |
| 2013 Q2 | -2.38 Billion USD | -3706.06% |
| 2013 Q1 | 66 Million USD | 100.82% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | -3 Billion USD | -186.17% |
| 2012 Q2 | - USD | 100.0% |
| 2012 FY | - USD | -80611.51% |
| 2012 Q4 | -8.02 Billion USD | 0.0% |
| 2011 Q3 | 1.56 Million USD | 0.0% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q1 | 211 Million USD | -96.35% |
| 2011 Q4 | 3.48 Billion USD | 223100.06% |
| 2011 FY | - USD | -5.47% |
| 2010 Q1 | -2.53 Billion USD | -144.57% |
| 2010 Q4 | 5.77 Billion USD | 0.0% |
| 2010 FY | - USD | 56.78% |
| 2010 Q3 | - USD | 100.0% |
| 2010 Q2 | -3.24 Billion USD | -27.97% |
| 2009 Q3 | -2.17 Billion USD | 33.69% |
| 2009 Q4 | 5.69 Billion USD | 361.36% |
| 2009 FY | - USD | 99.77% |
| 2009 Q1 | -260 Million USD | 97.99% |
| 2009 Q2 | -3.28 Billion USD | -1163.85% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | -12.95 Billion USD | 0.0% |
| 2008 FY | - USD | -40.14% |
| 2008 Q1 | - USD | 100.0% |
| 2007 Q3 | - USD | 100.0% |
| 2007 Q4 | -7.78 Billion USD | 0.0% |
| 2007 FY | - USD | 69.16% |
| 2007 Q1 | 617 Million USD | 444.69% |
| 2007 Q2 | -2 Billion USD | -425.12% |
| 2006 Q2 | -22.75 Billion USD | -581.29% |
| 2006 Q4 | -179 Million USD | 0.0% |
| 2006 FY | - USD | -107.56% |
| 2006 Q1 | -3.34 Billion USD | -6.95% |
| 2005 Q4 | -3.12 Billion USD | 15.5% |
| 2005 Q3 | -3.69 Billion USD | -78.98% |
| 2005 Q2 | -2.06 Billion USD | 62.83% |
| 2005 Q1 | -5.55 Billion USD | 50.74% |
| 2005 FY | - USD | 52.03% |
| 2004 FY | - USD | -173.16% |
| 2004 Q2 | -7.87 Billion USD | -35.59% |
| 2004 Q3 | -5.13 Billion USD | 34.75% |
| 2004 Q1 | -5.8 Billion USD | 27.81% |
| 2004 Q4 | -11.27 Billion USD | -119.5% |
| 2003 Q3 | -759 Million USD | 74.48% |
| 2003 Q2 | -2.97 Billion USD | 0.0% |
| 2003 FY | - USD | 43.75% |
| 2003 Q4 | -8.04 Billion USD | -959.82% |
| 2003 Q1 | - USD | 100.0% |
| 2002 Q2 | -6.04 Billion USD | -3.85% |
| 2002 FY | - USD | -8.18% |
| 2002 Q4 | -2.86 Billion USD | 41.05% |
| 2002 Q3 | -4.85 Billion USD | 19.62% |
| 2002 Q1 | -5.82 Billion USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | -4.96 Billion USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 31.385% |
| Arem Pacific Corporation | 36.71 Thousand USD | 20626.717% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | -6574.623% |
| BioCorRx Inc. | -2.68 Million USD | -180.797% |
| Bionik Laboratories Corp. | -4.77 Million USD | -57.807% |
| Banyan Corp. | 583.94 Thousand USD | 1390.605% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | 58644.116% |
| Quantum Medical Transport, Inc. | - USD | Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | -592.505% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | -241.045% |
| Selectis Health, Inc. | -7.29 Million USD | -3.32% |
| Ethema Health Corporation | 2.07 Million USD | 463.695% |
| HealthLynked Corp. | -2.75 Million USD | -174.02% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | -183.922% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | 26226.271% |
| Comjoyful International Company | 167.89 Thousand USD | 4588.748% |
| Medical Facilities Corporation | 77.94 Million USD | 109.669% |
| MedSmart Group Inc. | 47.8 Thousand USD | 15863.526% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | -1109.052% |
| Nova Leap Health Corp. | 994.46 Thousand USD | 857.833% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | -3635.877% |
| PAO Group, Inc. | 292.96 Thousand USD | 2672.47% |
| Primemd Inc. | 3.42 Million USD | 319.916% |
| Raffles Medical Group Ltd | 100.7 Million USD | 107.484% |
| Ryman Healthcare Limited | -54.51 Million USD | 86.176% |
| Stem Cell Authority, Ltd. | -4233.00 USD | -177938.838% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | -160.392% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | -1256.668% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | -15280.376% |
| Veltex Corporation | -938.45 Thousand USD | -703.061% |
| World Financial Holding Group | -28.43 Thousand USD | -26408.561% |
| Xcelerate Inc. | -2.53 Million USD | -196.902% |